Upcoming MACRAMÉ Events & Presentations
Meet MACRAMÉ Partners at upcoming conferences to hear about the latest results of MACRAMÉ
Meet MACRAMÉ Partners at upcoming conferences to hear about the latest results of MACRAMÉ
On Monday, 19. January 2026, the European Health and Digital Executive Agency (HaDEA) will be holding the second edition of the HaDEA Showcase Event, we will highlight EU-funded projects and synergies from across HaDEA’s portfolio, in the context of key EU policy initiatives; the Competitiveness Compass and the EU Preparedness Union Strategy. The full agenda is available here. Dr Read more
In 2025, MACRAMÉ Partners presented key results in posters and talks and attended panel discussions at various events.
MACRAMÉ colleagues from EMPA contributed to the publication ‘Boron Nitride Nanomaterials Trigger Immunomodulatory Effects in Human Broncho-Epithelial Cells by Modulating Eicosanoid Lipid Signaling’. For the successful commercial development of emerging 2D materials, it is crucial to understand their potential biological effects on healthy and diseased individuals.
MACRAMÉ Partners presented key outcomes and used the great opportunity to discuss with many experts at the SSbD Conference 2025, 10th – 12th November, 2025 in Zurich (Switzerland)
MyBiotech GmbH is a dynamic CDMO headquartered in Germany offering end-to-end development, manufacturing services, and cutting‑edge products for the biotechnology and pharmaceutical sectors. …
Continuing the NanoHarmony NANOMET journey: Harmonisation & Standardisation of Test Methodsfor Nanomaterials and Advanced Materials– Where did our research projects get us, and where do we go from here? *** ONLINE *** 3rd & 4th November 2025 The Horizon Europe projects MACRAMÉ, iCARE, nanoPASS and DESIDERATA invite you to an exclusive Read more
Seven Past Nine GmbH (7P9-DE) is a micro-company dedicated to advancing data stewardship across collaborative scientific research projects and, as the name suggests, a sister company of the Slovenian Seven Past Nine d.o.o. (7P9-SI). The driving force behind the company’s vision for harmonised data management is Thomas Exner, the founder Read more
The ‘Joint Risk Assessor Summit on Advancing Safety & Sustainability Assessments of Advanced Materials’ hosted by ACCORDs, iCARE, MACRAMÉ, and nanoPASS, was a full success. To address new challenges for safety and sustainability assessment coming with advanced materials, the EU Horizon Europe projects ACCORDs, iCARE, MACRAMÉ, and nanoPASS hosted the Read more
The development of new approach methodologies (NAMs) to replace current in vivo testing for the safety assessment of engineered nanomaterials (ENMs) is hindered by the scarcity of validated experimental data for many ENMs. MACRAMÉ partners contributed to the publication ‘Wisdom of Crowds for Supporting the Safety Evaluation of Nanomaterials’.